Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Bristol-Myers Squibb Co (NYSE: BMY) closed at $60.08 in the last session, up 0.30% from day before closing price of $59.90. In other words, the price has increased by $0.30 from its previous closing price. On the day, 8.3 million shares were traded. BMY stock price reached its highest trading level at $60.55 during the session, while it also had its lowest trading level at $59.46.
Ratios:
We take a closer look at BMY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.74. For the most recent quarter (mrq), Quick Ratio is recorded 1.15 and its Current Ratio is at 1.25. In the meantime, Its Debt-to-Equity ratio is 3.13 whereas as Long-Term Debt/Eq ratio is at 3.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 20 ’25 when BOERNER CHRISTOPHER S. bought 2,000 shares for $55.05 per share. The transaction valued at 110,096 led to the insider holds 104,626 shares of the business.
Hirawat Samit bought 1,823 shares of BMY for $100,000 on Feb 14 ’25. The EVP,Chief Med.Offr.,Drug Dev. now owns 63,932 shares after completing the transaction at $54.84 per share. On Nov 04 ’24, another insider, Holzer Phil M, who serves as the SVP and Controller of the company, sold 700 shares for $55.62 each. As a result, the insider received 38,930 and left with 11,760 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 121920946176 and an Enterprise Value of 162260451328. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.52 while its Price-to-Book (P/B) ratio in mrq is 7.46. Its current Enterprise Value per Revenue stands at 3.359 whereas that against EBITDA is 8.361.
Stock Price History:
The Beta on a monthly basis for BMY is 0.42, which has changed by 0.16456676 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, BMY has reached a high of $63.33, while it has fallen to a 52-week low of $39.35. The 50-Day Moving Average of the stock is 3.47%, while the 200-Day Moving Average is calculated to be 15.22%.
Shares Statistics:
According to the various share statistics, BMY traded on average about 11.64M shares per day over the past 3-months and 12380080 shares per day over the past 10 days. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 79.95% stake in the company. Shares short for BMY as of 1740700800 were 30571531 with a Short Ratio of 2.63, compared to 1738281600 on 26695018. Therefore, it implies a Short% of Shares Outstanding of 30571531 and a Short% of Float of 1.50999995.
Dividends & Splits
The forward annual dividend rate for BMY is 2.42, which was 2.42 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.04040067The stock’s 5-year Average Dividend Yield is 3.5. The current Payout Ratio is 59.82% for BMY, which recently paid a dividend on 2025-01-03 with an ex-dividend date of 1743724800. Stock splits for the company last occurred on 2001-08-07 when the company split stock in a 1000000:951777 ratio.
